AIRLINK 70.30 Decreased By ▼ -2.76 (-3.78%)
BOP 4.89 Decreased By ▼ -0.20 (-3.93%)
CNERGY 4.28 Decreased By ▼ -0.09 (-2.06%)
DFML 31.23 Decreased By ▼ -1.22 (-3.76%)
DGKC 76.60 Increased By ▲ 1.11 (1.47%)
FCCL 19.70 Increased By ▲ 0.18 (0.92%)
FFBL 34.35 Decreased By ▼ -1.80 (-4.98%)
FFL 9.12 Decreased By ▼ -0.10 (-1.08%)
GGL 9.79 Decreased By ▼ -0.06 (-0.61%)
HBL 113.00 Decreased By ▼ -3.70 (-3.17%)
HUBC 132.20 Decreased By ▼ -0.49 (-0.37%)
HUMNL 6.98 Decreased By ▼ -0.12 (-1.69%)
KEL 4.23 Decreased By ▼ -0.18 (-4.08%)
KOSM 4.27 Decreased By ▼ -0.13 (-2.95%)
MLCF 36.30 Increased By ▲ 0.10 (0.28%)
OGDC 132.80 Decreased By ▼ -0.70 (-0.52%)
PAEL 22.08 Decreased By ▼ -0.52 (-2.3%)
PIAA 24.75 Decreased By ▼ -1.26 (-4.84%)
PIBTL 6.45 Decreased By ▼ -0.10 (-1.53%)
PPL 116.90 Increased By ▲ 1.59 (1.38%)
PRL 25.85 Decreased By ▼ -0.78 (-2.93%)
PTC 13.31 Decreased By ▼ -0.79 (-5.6%)
SEARL 51.99 Decreased By ▼ -1.46 (-2.73%)
SNGP 67.98 Increased By ▲ 0.73 (1.09%)
SSGC 10.53 Decreased By ▼ -0.17 (-1.59%)
TELE 8.27 Decreased By ▼ -0.15 (-1.78%)
TPLP 10.77 Increased By ▲ 0.02 (0.19%)
TRG 59.69 Decreased By ▼ -4.18 (-6.54%)
UNITY 25.25 Increased By ▲ 0.13 (0.52%)
WTL 1.27 No Change ▼ 0.00 (0%)
BR100 7,382 Decreased By -79.3 (-1.06%)
BR30 23,902 Decreased By -269.7 (-1.12%)
KSE100 70,599 Decreased By -503.9 (-0.71%)
KSE30 23,229 Decreased By -165.3 (-0.71%)

FRANKFURT AM MAIN: The boss of German chemicals giant Bayer insisted Sunday its multi-billion dollar takeover of Monsanto was a "good idea", despite huge legal costs piling up over its Roundup weedkiller.

"The Monsanto acquisition was and is a good idea," Werner Baumann told newspaper Frankfurter Allgemeine Sonntagszeitung, when asked if he would have changed his mind about buying the US group if he could.

Bayer bought Monsanto for $63 billion but the deal has turned out to be plagued with other massive costs.

Just two months after the acquisition was completed, Monsanto lost a case to a school groundskeeper suffering from terminal non-Hodgkin's lymphoma, who had sued the company over the glyphosate weedkillers Roundup and Ranger Pro.

Monsanto was initially ordered to pay $289 million to Johnson, before the damages were reduced to $78.5 million.

Bayer has filed an appeal.

The company suffered a new set back this month as a US jury ruled that Roundup was a "substantial factor" in another case brought by an amateur gardener who was suffering from cancer.

It now faces a total of 11,200 US cases over Roundup and its active ingredient glyphosate, a herbicide key to Monsanto's business model that has come in for intense scrutiny around the world.

Werner insisted the acquisition of Monsanto was carried out after careful due diligence.

Bayer has also pointed to findings from regulators around the world, especially in advanced economies like the US, Europe and Canada, and reams of scientific studies as proof of the safety of its product.

"Regulatory authorities around the world consider glyphosate-based herbicides as safe when used as directed," the group has argued, highlighting "800 rigorous studies" of glyphosate's effects.

The World Health Organization's International Agency for Research on Cancer found in 2015 that glyphosate is "probably carcinogenic," although the European Food Safety Authority and the European Chemicals Agency have not issued similar judgments.

Since the Monsanto takeover was completed, Bayer's stock has shed almost 40 percent of its value.

Copyright AFP (Agence France-Press), 2019
 

 

 

Comments

Comments are closed.